ESICM News

UCARDS: Use of CARdiovascular Drugs in Shock

UCARDS: Use of CARdiovascular Drugs in Shock

UCARDS: Use of CARdiovascular Drugs in Shock

Participate in this survey now!

In shock, organs are hypoperfused leading to dysfunction or death at a cellular level, as well as disruption in cardiovascular functions. Cardiovascular drugs are often used to manage patients in this state, despite the lack of consensus on their use. This survey from the Cardiovascular Dynamics Section aims to evaluate the indications, current practice, and therapeutic goals in European ICU‘s on the use of cardiovascular drugs in the treatment of shock states.

Participate now: CLICK HERE

Contacts: Jean-Louis TEBOUL, Chair ESICM Cardiovascular Dynamics Section

Thomas SCHEEREN, Deputy for the Cardiovascular Dynamics Section

To take part in other open surveys, visit our dedicated webpage.

<Back to the news list
Comment on this news Comment on this news
To respond to this article, thank you for identifying
ReactionsReactions (0)